首页> 外国专利> HCTLA4-IG FUSION PROTEIN-CODING GENE, RECOMBINANT VECTOR COMPRISING THE SAME, AND PROCESS FOR PRODUCING HCTLA4-IG FUSION PROTEIN USING THE SAME

HCTLA4-IG FUSION PROTEIN-CODING GENE, RECOMBINANT VECTOR COMPRISING THE SAME, AND PROCESS FOR PRODUCING HCTLA4-IG FUSION PROTEIN USING THE SAME

机译:HCTLA4-IG融合蛋白编码基因,包含其的重组载体和使用该重组蛋白生产HCTLA4-IG融合蛋白的方法

摘要

Provided are a gene coding for a human cytotoxic T lymphocyte antigen 4-Immunoglobulin (hCTLA4-Ig) fusion protein comprising a plant-derived leader sequence, and recombinant vectors pMYN409, pMYN413 and pMYN414, comprising the same. Provided are also host cells transformed with the above-mentioned recombinant vectors, a process for producing a recombinant hCTLA4-Ig fusion protein, involving suspension culturing the host cells, and an hCTLA4-Ig fusion protein prepared using the same. In accordance with the present invention, it is possible to achieve mass production of the recombinant hCTLA4-Ig fusion protein having immunosuppressive activity equal to that of the hCTLA4-Ig fusion protein expressed in conventional animal cells, by use of plant cell suspension culture. Thereby, recombinant proteins can be produced more efficiently and economically, as compared to animal cell culture techniques.
机译:提供了编码包含植物来源的前导序列的人细胞毒性T淋巴细胞抗原4-免疫球蛋白(hCTLA4-Ig)融合蛋白的基因,以及包含其的重组载体pMYN409,pMYN413和pMYN414。还提供了用上述重组载体转化的宿主细胞,产生重组hCTLA4-Ig融合蛋白的方法,该方法涉及悬浮培养宿主细胞,以及使用它们制备的hCTLA4-Ig融合蛋白。根据本发明,通过使用植物细胞悬浮培养物,可以大规模生产具有与常规动物细胞中表达的hCTLA4-Ig融合蛋白相同的免疫抑制活性的重组hCTLA4-Ig融合蛋白。因此,与动物细胞培养技术相比,重组蛋白可以更有效和经济地生产。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号